Diabetic Nephropathy
📧 Sign up to get email alerts when something new happens for Diabetic Nephropathy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-02-09Clinical Trial Update: A Study to Evaluate Pharmacodynamics, Safety, Tolerability and Pharmacokinetics of MT-3995 in Type II Diabetic Nephropathy Subjects With Albuminuria and Moderately Decreased GFR [Phase 2]
This Phase 2 trial update reports on pharmacodynamics, safety, tolerability, and pharmacokinetics of MT-3995 in patients with diabetic nephr…
-
CLINICAL_TRIALS trial_result · 2015-02-09Clinical Trial Update: A Study to Evaluate Pharmacodynamics, Safety, Tolerability and Pharmacokinetics of MT-3995 in Type II Diabetic Nephropathy Subjects With Albuminuria [Phase 2]
A Phase 2 study to evaluate pharmacodynamics, safety, tolerability and pharmacokinetics of MT-3995 in adults with type 2 diabetic nephropath…
-
CLINICAL_TRIALS trial_result · 2015-01-27Clinical Trial Update: Safety, Tolerability and Pharmacokinetic Study of MT-3995 in Subjects With Diabetic Nephropathy [Phase 1, Phase 2]
This clinical trial update summarizes a Phase 1/2 study of MT-3995 in diabetic nephropathy, focusing on safety, tolerability, and pharmacoki…
-
CLINICAL_TRIALS trial_result · 2015-01-09Clinical Trial Update: PREVENTKD (Prevent Risks by Early interVEntion at Nighttime in Type 1 Diabetes for Kidney Disease) [Phase 3]
The PREVENTKD Phase 3 trial in type 1 diabetes mellitus was terminated and results were posted in January 2015.
-
CLINICAL_TRIALS trial_result · 2014-10-27Clinical Trial Update: Pioglitazone and Losartan Provides Additional Renoprotection [NA]
A completed clinical trial evaluating pioglitazone plus losartan suggests additional renoprotective effects in patients with type 2 diabetes…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-07-18Clinical Trial Update: Effect of Integrated CKD Care Program in Early Diabetic Nephropathy in Primary Health Care Setting. [NA]
A completed clinical trial evaluating an integrated chronic kidney disease care program for patients with early diabetic nephropathy in a pr…
-
CLINICAL_TRIALS trial_result · 2014-05-15Clinical Trial Update: Aldosterone Breakthrough During Diovan, Tekturna, and Combination Therapy in Patients With Proteinuric Kidney Disease [Phase 4]
Phase 4 trial evaluating aldosterone breakthrough during Diovan, Tekturna, and combination therapy in proteinuric kidney disease was termina…
-
CLINICAL_TRIALS trial_result · 2014-04-09Clinical Trial Update: The Effects of Sevelamer Carbonate on Diabetic Nephropathy [Phase 2]
A Phase 2 clinical trial evaluating sevelamer carbonate for diabetic nephropathy has been completed, with no results detailed in the snippet…
-
CLINICAL_TRIALS trial_result · 2013-12-17Clinical Trial Update: Single Dose, Single Administration Study of Technosphere Inhalation Powder in Diabetic Subjects With Mild or Moderate Kidney Disease Compared to Diabetic Subjects With Normal Kidney Function [Phase 1]
A Phase 1 single-dose study evaluating Technosphere Inhalation Powder (inhaled insulin) in diabetic subjects with mild or moderate nephropat…
-
CLINICAL_TRIALS trial_result · 2013-11-19Clinical Trial Update: Renoprotection in Early Diabetic Nephropathy in Pima Indians [Phase 3]
Phase 3 trial evaluating renoprotective strategies in early diabetic nephropathy among Pima Indians; trial completed with results posted in …
-
CLINICAL_TRIALS trial_result · 2013-11-13Clinical Trial Update: 1 Year Trial Telmisartan 80 mg Versus Valsartan 160 mg in Hypertensive Type 2 Diabetic Patients With Overt Nephropathy [Phase 4]
A completed Phase 4 trial compared telmisartan 80 mg to valsartan 160 mg over one year in hypertensive patients with type 2 diabetes and ove…
-
CLINICAL_TRIALS trial_result · 2013-11-01Clinical Trial Update: INNOVATION Study - Telmisartan (Micardis) in Incipient Diabetic Nephropathy [Phase 4]
This is a Phase 4 clinical trial update for Telmisartan (Micardis) in incipient diabetic nephropathy, sponsored by Boehringer Ingelheim; the…
-
CLINICAL_TRIALS trial_result · 2013-10-28Clinical Trial Update: Triple Blockade of the Renin Angiotensin Aldosterone System in Diabetic (Type 1&2) Proteinuric Patients [Phase 4]
Phase 4 trial evaluating triple blockade of the renin-angiotensin-aldosterone system in proteinuric diabetic patients (Type 1 and Type 2) ha…
-
CLINICAL_TRIALS trial_result · 2013-10-25Clinical Trial Update: A Prospective, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate Efficacy and Safety of Atrasentan, Including Thoracic Bioimpedance, in Type 2 Diabetic Subjects With Nephropathy [Phase 2]
A Phase 2 multicenter, double-blind, placebo-controlled study evaluating atrasentan, including thoracic bioimpedance, in adults with type 2 …
-
CLINICAL_TRIALS trial_result · 2013-09-23Clinical Trial Update: A Study To Evaluate The Safety And Tolerability Of PF-03882845 In Patients With Type 2 Diabetic Nephropathy [Phase 1]
A Phase 1 study evaluating the safety and tolerability of PF-03882845 in patients with diabetic nephropathy due to type 2 diabetes. The tria…
-
CLINICAL_TRIALS trial_result · 2013-08-28Clinical Trial Update: Evaluate the Efficacy and Safety of Once Daily Administration of Atrasentan Tablets (Low and High) Compared to Placebo in Reducing Residual Albuminuria in Type 2 Diabetic Patients With Nephropathy Who Are Treated With the Maximum Tolerated Labeled Dose of a Renin Angiotensin System (RAS) Inhibitor [Phase 2]
A Phase 2 trial evaluated the efficacy and safety of once-daily atrasentan tablets (low and high doses) versus placebo in reducing residual …
-
CLINICAL_TRIALS trial_result · 2013-06-06Clinical Trial Update: Serum 1,25-dihydroxyvitamin D Levels in Type 2 Diabetes Mellitus Patients With Different Levels of Albuminuria
This completed clinical trial examined serum 1,25-dihydroxyvitamin D levels in patients with type 2 diabetes and varying levels of albuminur…
-
CLINICAL_TRIALS trial_result · 2013-05-31Clinical Trial Update: Adrenocorticotropic Hormone (ACTH) Treatment of Nephrotic Range Proteinuria in Diabetic Nephropathy (NRDN) [Phase 4]
Phase 4 clinical trial evaluating adrenocorticotropic hormone (ACTH) for nephrotic-range proteinuria in patients with diabetic nephropathy; …
-
CLINICAL_TRIALS trial_result · 2013-05-08Clinical Trial Update: A Clinical Study to Evaluate the Efficacy and Safety of Cilostazol and Probucol in Combination on Patients With Diabetic Nephropathy [Phase 4]
A Phase 4 clinical study evaluating the efficacy and safety of combining cilostazol and probucol in patients with diabetic nephropathy has c…
-
CLINICAL_TRIALS trial_result · 2013-03-14Clinical Trial Update: Sex-specific Association With Kidney Disease
A completed clinical trial studying sex-specific associations with kidney disease in diabetic nephropathy. The sponsor listed is University …
-
CLINICAL_TRIALS trial_result · 2013-01-16Clinical Trial Update: SLC2A1 Variants and Diabetic Nephropathy
A completed clinical trial from University of Sao Paulo General Hospital studied SLC2A1 gene variants in relation to diabetic nephropathy.
-
CLINICAL_TRIALS trial_result · 2013-01-04Clinical Trial Update: Colchicine for Diabetic Nephropathy [Phase 2]
Phase 2 clinical trial investigating colchicine for diabetic nephropathy; current status is unknown.
-
CLINICAL_TRIALS trial_result · 2012-12-06Clinical Trial Update: Ramipril and Clopidogrel in Oxidative Stress, Vascular Inflammation and Endothelial Dysfunction in Type 2 Diabetes and Diabetic Nephropathy [Phase 4]
This is a Phase 4 clinical trial evaluating the effects of ramipril and clopidogrel on oxidative stress, vascular inflammation, and endothel…
-
CLINICAL_TRIALS trial_result · 2012-11-30Clinical Trial Update: Effect of Calcium Channel Blocker on the Serum Fibrobalst Growth Factor-23 (FGF-23) Levels in Type-2 Diabetic Patients With Proteinuria Purpose [Phase 4]
Phase 4 study assessing whether the calcium channel blocker amlodipine influences serum FGF-23 levels and other clinical/laboratory paramete…
-
CLINICAL_TRIALS trial_result · 2012-11-12Clinical Trial Update: Prevention of Renal Complications of Diabetes With Thiamine [Phase 4]
This ClinicalTrials.gov update reports on a Phase 4 trial evaluating thiamine to prevent renal complications in diabetic nephropathy. The cu…